Skip to main content
SpringerLink
Log in

Cancer

Risk of hypogonadism in male survivors of childhood cancer

  • News & Views
  • Published:

From Nature Reviews Endocrinology

View current issue Sign up to alerts

New results suggest that male survivors of childhood cancer are at an increased risk of developing low testosterone levels in adult life. Are the data convincing enough to recommend screening for hypogonadism in men treated with chemotherapy and radiotherapy during childhood?

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Romerius, P. et al. Hypogonadism risk in men treated for childhood cancer. J. Clin. Endocrinol. Metab. 94, 4180–4186 (2009).

    Article  CAS  PubMed  Google Scholar 

  2. Greenfield, D. M. et al. Prevalence and consequences of androgen deficiency in young male cancer survivors in a controlled cross-sectional study. J. Clin. Endocrinol. Metab. 92, 3476–3482 (2007).

    Article  CAS  PubMed  Google Scholar 

  3. Bremner, W. J., Vitiello, M. V. & Prinz, P. N. Loss of circadian rhythmicity in blood testosterone levels with aging in normal men. J. Clin. Endocrinol. Metab. 56, 1278–1281 (1983).

    Article  CAS  PubMed  Google Scholar 

  4. Spratt, D. I. et al. Neuroendocrine-gonadal axis in men: frequent sampling of, LH, FSH, and testosterone. Am. J. Physiol. 254, E658–E666 (1988).

    CAS  PubMed  Google Scholar 

  5. Swerdloff, R. S. et al. Long-term pharmacokinetics of transdermal testosterone gel in hypogonadal men. J. Clin. Endocrinol. Metab. 85, 4500–4510 (2000).

    CAS  PubMed  Google Scholar 

  6. Howell, S. J. et al. Randomized placebo-controlled trial of testosterone replacement in men with mild Leydig cell insufficiency following cytotoxic chemotherapy. Clin. Endocrinol. (Oxf.) 55, 315–324 (2001).

    Article  CAS  Google Scholar 

  7. Bhasin, S. et al. Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 91, 1995–2010 (2006).

    Article  CAS  PubMed  Google Scholar 

  8. Araujo, A. B. et al. Prevalence of symptomatic androgen deficiency. J. Clin. Endocrinol. Metab. 92, 4241–4247 (2007).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Endocrinology, St Vincent's University Hospital, Elm Park, Dublin 4, Ireland

    Tomas Ahern & Frances J. Hayes

Authors
  1. Tomas Ahern
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Frances J. Hayes
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Frances J. Hayes.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ahern, T., Hayes, F. Risk of hypogonadism in male survivors of childhood cancer. Nat Rev Endocrinol 6, 129–130 (2010). https://doi.org/10.1038/nrendo.2009.277

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrendo.2009.277

  • Springer Nature Limited

Search

Navigation